# | pmid | doi | year | title | Hugo_Symbol |
---|---|---|---|---|---|
1 | 34110462 | 10.1007/s00277-020-04357-z | 2021 | Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1<sup>T315I</sup> and BCR-ABL1<sup>T315I-E255K</sup>. | ZFAT |